Skip to content
OpenCapital
Get started

Aurinia Pharmaceuticals AUPH Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Rogers Corporation logo
Rogers CorporationROG
$4M-2.4%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$18.81M+9.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$4.44M-14.8%
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
$3.17M+38.3%
Alumis Inc. logo
Alumis Inc.ALMS
$4.44M+74.5%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$3.14M-21.1%

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.3B+78.5%
Enterprise value$2.34B+78.3%
P/E7.7×-24.6×
P/S7.7×+2.5×

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's operating lease liabilities (current)?
Aurinia Pharmaceuticals (AUPH) reported operating lease liabilities (current) of $1.62M in Q1 2026.
How has Aurinia Pharmaceuticals's operating lease liabilities (current) changed year-over-year?
Aurinia Pharmaceuticals's operating lease liabilities (current) increased by 56.6% year-over-year, from $1.04M to $1.62M.
What is the long-term trend for Aurinia Pharmaceuticals's operating lease liabilities (current)?
Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's operating lease liabilities (current) has grown at a 6.2% compound annual growth rate (CAGR), from $788K to $1.07M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.